AG
MRK icon

Ascent Group’s Merck MRK Stock Holding History

Ascent Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.31M Buy
41,325
+4,135
+11% +$484K 0.16% 130
2026
Q1 		$4.47M Sell
37,190
-439
-1% -$50.7K 0.15% 132
2025
Q4 		$3.96M Buy
37,629
+2,319
+7% +$218K 0.14% 145
2025
Q3 		$2.96M Buy
35,310
+18,843
+114% +$1.55M 0.1% 182
2025
Q2 		$1.3M Sell
16,467
-38,049
-70% -$3.02M 0.05% 286
2025
Q1 		$4.89M Buy
54,516
+11,506
+27% +$1.07M 0.21% 103
2024
Q4 		$4.28M Sell
43,010
-2,921
-6% -$301K 0.32% 79
2024
Q3 		$5.22M Sell
45,931
-1,821
-4% -$216K 0.4% 54
2024
Q2 		$5.91M Sell
47,752
-3,670
-7% -$473K 0.48% 44
2024
Q1 		$6.79M Buy
51,422
+14,974
+41% +$1.85M 0.6% 31
2023
Q4 		$4.57M Buy
36,448
+415
+1% +$43.1K 0.43% 49
2023
Q3 		$3.69M Buy
36,033
+2,870
+9% +$309K 0.41% 54
2023
Q2 		$3.53M Sell
33,163
-10,182
-23% -$1.16M 0.39% 61
2023
Q1 		$4.61M Sell
43,345
-8,780
-17% -$948K 0.49% 40
2022
Q4 		$5.78M Buy
52,125
+989
+2% +$101K 0.68% 21
2022
Q3 		$5.17M Buy
51,136
+6,123
+14% +$547K 0.63% 28
2022
Q2 		$4.02M Buy
45,013
+6,177
+16% +$548K 0.48% 45
2022
Q1 		$3.19M Buy
38,836
+1,433
+4% +$113K 0.37% 87
2021
Q4 		$2.99M Buy
+37,403
New +$2.98M 0.38% 88

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ascent Group's MRK Position: Q2 2026 in Review

Ascent Group increased its Merck (MRK) stake by 11% in Q2 2026, buying an estimated $484K and bringing the position to 41,325 shares worth $5.31M. The position accounts for 0.16% of the portfolio, ranked #130.

Ascent Group first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.79M in Q1 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Ascent Group held 41,325 shares of Merck worth $5.31M as of Q2 2026.
  • Ascent Group bought 4,135 Merck shares in Q2 2026, an estimated $484K.
  • Merck made up 0.16% of Ascent Group's portfolio in Q2 2026, its #130 holding.
  • Ascent Group first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • Ascent Group's Merck position peaked at $6.79M in Q1 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.